Publications

The First Clinical Use of a Novel Cold Storage System of Donor Hearts

Naito, et al.Journal of Heart and Lung TransplantationApril 2019; Volume 38, Issue 4, S44.https://doi.org/10.1016/j.healun.2019.01.093 Purpose : Current cold storage heart preservation technique is associated with wide fluctuation of organ temperature and may result in freeze injury. SheraPak™ Cardiac Transport System (CTS) (Paragonix Technologies, MA, USA) was recently approved in the United

Read More »

Oxygen consumption during oxygenated hypothermic perfusion as a measure of donor organ viability.

Bunegin L, Tolstykh GP, Gelineau JF, Cosimi AB, Anderson LMASAIO Journal2013 Jul-Aug; 59(4):427-32https://www.ncbi.nlm.nih.gov/pubmed/23820283 Hypothermic machine perfusion (HMP) for the preservation of kidneys, recovered from extended criteria organ donors (ECDs), presents the opportunity for assessing ex vivo parameters that may have value in predicting postimplantation organ viability. Organ perfusion and vascular resistance are the

Read More »

The application of fluidics technology for organ preservation.

Abstract A prototype design of a portable, pulsatile, perfusion preservation device based on a novel application of fluidics technology was tested to evaluate its ability to oxygenate preservation solution and to examine the relationship between organ resistance, perfusion pressure, and perfusion flow characteristics. The effects of organ resistance on pulse rate, perfusion pressure, and perfusion flow were modeled. Interstitial PO2 in

Read More »

ISHLT Industry Theater Request

2020 ISHLT Paragonix SherpaPak™ Summit

Industry Theater: April 23rd 10:30-11:30am